Head to Head Review: EUDA Health (NASDAQ:EUDA) vs. Hims & Hers Health (NYSE:HIMS)

EUDA Health (NASDAQ:EUDA) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, dividends, profitability, valuation and risk.

Earnings and Valuation

This table compares EUDA Health and Hims & Hers Health”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
EUDA Health	$6.82 million	6.59	-$2.77 million	($2.40)	-6.26
Hims & Hers Health	$2.35 billion	3.39	$128.37 million	($0.09)	-381.52

Hims & Hers Health has higher revenue and earnings than EUDA Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than EUDA Health, indicating that it is currently the more affordable of the two stocks.

Insider and Institutional Ownership

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares EUDA Health and Hims & Hers Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
EUDA Health	N/A	N/A	N/A
Hims & Hers Health	-0.56%	6.10%	1.52%

Volatility & Risk

EUDA Health has a beta of 0.64, suggesting that its share price is 36% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.37, suggesting that its share price is 137% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for EUDA Health and Hims & Hers Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
EUDA Health	1	1	1	0	2.00
Hims & Hers Health	2	10	4	0	2.13

EUDA Health currently has a consensus price target of $55.00, suggesting a potential upside of 265.93%. Hims & Hers Health has a consensus price target of $29.37, suggesting a potential downside of 14.48%. Given EUDA Health’s higher possible upside, equities research analysts clearly believe EUDA Health is more favorable than Hims & Hers Health.

Summary

Hims & Hers Health beats EUDA Health on 10 of the 14 factors compared between the two stocks.

About EUDA Health

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses. The company is also involved in the property management that services shopping malls, business office building, or residential apartments. EUDA Health Holdings Limited is headquartered in Singapore.

About Hims & Hers Health

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.